CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Clinical trial NCT03168256 · COMPLETED

Trial details

NCT number: NCT03168256
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2018-09-15
Primary completion: 2022-01-06
Enrollment: 528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.